[English] 日本語
Yorodumi
- PDB-6y1j: 14-3-3 sigma in complex with IkappaBalpha pS63 peptide -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 6y1j
Title14-3-3 sigma in complex with IkappaBalpha pS63 peptide
Components
  • 14-3-3 protein sigma
  • NF-kappa-B inhibitor alpha
KeywordsPEPTIDE BINDING PROTEIN / 14-3-3 sigma / IkBa / Nf-kB
Function / homology
Function and homology information


I-kappaB/NF-kappaB complex / cytoplasmic sequestering of NF-kappaB / negative regulation of myeloid cell differentiation / nucleotide-binding oligomerization domain containing 1 signaling pathway / IkBA variant leads to EDA-ID / molecular sequestering activity / RIP-mediated NFkB activation via ZBP1 / SUMOylation of immune response proteins / nucleotide-binding oligomerization domain containing 2 signaling pathway / transcription regulator inhibitor activity ...I-kappaB/NF-kappaB complex / cytoplasmic sequestering of NF-kappaB / negative regulation of myeloid cell differentiation / nucleotide-binding oligomerization domain containing 1 signaling pathway / IkBA variant leads to EDA-ID / molecular sequestering activity / RIP-mediated NFkB activation via ZBP1 / SUMOylation of immune response proteins / nucleotide-binding oligomerization domain containing 2 signaling pathway / transcription regulator inhibitor activity / interleukin-1-mediated signaling pathway / cellular response to cold / nuclear localization sequence binding / toll-like receptor 4 signaling pathway / response to exogenous dsRNA / negative regulation of NF-kappaB transcription factor activity / regulation of epidermal cell division / protein kinase C inhibitor activity / negative regulation of Notch signaling pathway / positive regulation of epidermal cell differentiation / keratinocyte development / keratinization / non-canonical NF-kappaB signal transduction / TRAF6 mediated NF-kB activation / response to muramyl dipeptide / positive regulation of cholesterol efflux / negative regulation of macrophage derived foam cell differentiation / negative regulation of lipid storage / Regulation of localization of FOXO transcription factors / keratinocyte proliferation / NF-kappaB binding / phosphoserine residue binding / positive regulation of transcription initiation by RNA polymerase II / Activation of BAD and translocation to mitochondria / negative regulation of keratinocyte proliferation / canonical NF-kappaB signal transduction / establishment of skin barrier / SARS-CoV-2 targets host intracellular signalling and regulatory pathways / Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex / negative regulation of canonical NF-kappaB signal transduction / protein kinase A signaling / negative regulation of stem cell proliferation / SARS-CoV-1 targets host intracellular signalling and regulatory pathways / RHO GTPases activate PKNs / Notch signaling pathway / lipopolysaccharide-mediated signaling pathway / tumor necrosis factor-mediated signaling pathway / response to muscle stretch / positive regulation of protein metabolic process / protein export from nucleus / negative regulation of innate immune response / NF-kB is activated and signals survival / protein sequestering activity / TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest / release of cytochrome c from mitochondria / positive regulation of protein export from nucleus / stem cell proliferation / Translocation of SLC2A4 (GLUT4) to the plasma membrane / TP53 Regulates Metabolic Genes / Activation of NF-kappaB in B cells / B cell receptor signaling pathway / negative regulation of protein kinase activity / TAK1-dependent IKK and NF-kappa-B activation / negative regulation of cysteine-type endopeptidase activity involved in apoptotic process / CLEC7A (Dectin-1) signaling / positive regulation of inflammatory response / FCERI mediated NF-kB activation / Interleukin-1 signaling / protein import into nucleus / SARS-CoV-1 activates/modulates innate immune responses / intrinsic apoptotic signaling pathway in response to DNA damage / Downstream TCR signaling / cellular response to tumor necrosis factor / regulation of cell population proliferation / positive regulation of cell growth / regulation of cell cycle / Ub-specific processing proteases / cadherin binding / apoptotic process / ubiquitin protein ligase binding / protein kinase binding / negative regulation of transcription by RNA polymerase II / enzyme binding / signal transduction / positive regulation of transcription by RNA polymerase II / extracellular space / extracellular exosome / nucleoplasm / identical protein binding / nucleus / plasma membrane / cytosol / cytoplasm
Similarity search - Function
Ankyrin repeats (many copies) / 14-3-3 protein sigma / 14-3-3 proteins signature 2. / 14-3-3 protein, conserved site / 14-3-3 proteins signature 1. / 14-3-3 protein / 14-3-3 homologues / 14-3-3 domain / 14-3-3 domain superfamily / 14-3-3 protein ...Ankyrin repeats (many copies) / 14-3-3 protein sigma / 14-3-3 proteins signature 2. / 14-3-3 protein, conserved site / 14-3-3 proteins signature 1. / 14-3-3 protein / 14-3-3 homologues / 14-3-3 domain / 14-3-3 domain superfamily / 14-3-3 protein / Ankyrin repeats (3 copies) / Ankyrin repeat profile. / Ankyrin repeat region circular profile. / ankyrin repeats / Ankyrin repeat / Ankyrin repeat-containing domain superfamily
Similarity search - Domain/homology
NF-kappa-B inhibitor alpha / 14-3-3 protein sigma
Similarity search - Component
Biological speciesHomo sapiens (human)
MethodX-RAY DIFFRACTION / SYNCHROTRON / MOLECULAR REPLACEMENT / Resolution: 1.127 Å
AuthorsWolter, M. / Ottmann, C.
Funding support Netherlands, 1items
OrganizationGrant numberCountry
European Commission Netherlands
CitationJournal: Acs Omega / Year: 2020
Title: Interaction of an I kappa B alpha Peptide with 14-3-3.
Authors: Wolter, M. / Santo, D.L. / Herman, P. / Ballone, A. / Centorrino, F. / Obsil, T. / Ottmann, C.
History
DepositionFeb 12, 2020Deposition site: PDBE / Processing site: PDBE
Revision 1.0Mar 4, 2020Provider: repository / Type: Initial release
Revision 1.1Apr 1, 2020Group: Database references / Category: citation / citation_author
Item: _citation.journal_volume / _citation.page_first ..._citation.journal_volume / _citation.page_first / _citation.page_last / _citation.pdbx_database_id_PubMed / _citation.title
Revision 1.2Jan 24, 2024Group: Data collection / Database references ...Data collection / Database references / Derived calculations / Refinement description
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_initial_refinement_model / pdbx_struct_conn_angle / struct_conn / struct_conn_type
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _pdbx_struct_conn_angle.ptnr1_auth_comp_id / _pdbx_struct_conn_angle.ptnr1_auth_seq_id / _pdbx_struct_conn_angle.ptnr1_label_asym_id / _pdbx_struct_conn_angle.ptnr1_label_atom_id / _pdbx_struct_conn_angle.ptnr1_label_comp_id / _pdbx_struct_conn_angle.ptnr1_label_seq_id / _pdbx_struct_conn_angle.ptnr1_symmetry / _pdbx_struct_conn_angle.ptnr2_symmetry / _pdbx_struct_conn_angle.ptnr3_auth_comp_id / _pdbx_struct_conn_angle.ptnr3_auth_seq_id / _pdbx_struct_conn_angle.ptnr3_label_asym_id / _pdbx_struct_conn_angle.ptnr3_label_atom_id / _pdbx_struct_conn_angle.ptnr3_label_comp_id / _pdbx_struct_conn_angle.ptnr3_label_seq_id / _pdbx_struct_conn_angle.ptnr3_symmetry / _pdbx_struct_conn_angle.value / _struct_conn.conn_type_id / _struct_conn.id / _struct_conn.pdbx_dist_value / _struct_conn.pdbx_leaving_atom_flag / _struct_conn.pdbx_ptnr1_label_alt_id / _struct_conn.pdbx_ptnr2_label_alt_id / _struct_conn.ptnr1_auth_asym_id / _struct_conn.ptnr1_auth_comp_id / _struct_conn.ptnr1_auth_seq_id / _struct_conn.ptnr1_label_asym_id / _struct_conn.ptnr1_label_atom_id / _struct_conn.ptnr1_label_comp_id / _struct_conn.ptnr1_label_seq_id / _struct_conn.ptnr2_auth_asym_id / _struct_conn.ptnr2_auth_comp_id / _struct_conn.ptnr2_auth_seq_id / _struct_conn.ptnr2_label_asym_id / _struct_conn.ptnr2_label_atom_id / _struct_conn.ptnr2_label_comp_id / _struct_conn.ptnr2_label_seq_id / _struct_conn.ptnr2_symmetry / _struct_conn_type.id

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: 14-3-3 protein sigma
P: NF-kappa-B inhibitor alpha
hetero molecules


Theoretical massNumber of molelcules
Total (without water)30,68813
Polymers29,9032
Non-polymers78511
Water6,017334
1
A: 14-3-3 protein sigma
P: NF-kappa-B inhibitor alpha
hetero molecules

A: 14-3-3 protein sigma
P: NF-kappa-B inhibitor alpha
hetero molecules


Theoretical massNumber of molelcules
Total (without water)61,37626
Polymers59,8064
Non-polymers1,56922
Water724
TypeNameSymmetry operationNumber
identity operation1_555x,y,z1
crystal symmetry operation4_555x,-y,-z1
Buried area7610 Å2
ΔGint-95 kcal/mol
Surface area23960 Å2
MethodPISA
Unit cell
Length a, b, c (Å)82.460, 111.820, 62.480
Angle α, β, γ (deg.)90.000, 90.000, 90.000
Int Tables number20
Space group name H-MC2221
Components on special symmetry positions
IDModelComponents
11A-408-

HOH

21A-722-

HOH

-
Components

-
Protein / Protein/peptide , 2 types, 2 molecules AP

#1: Protein 14-3-3 protein sigma / Epithelial cell marker protein 1 / Stratifin


Mass: 28226.518 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Homo sapiens (human) / Gene: SFN, HME1 / Production host: Escherichia coli (E. coli) / References: UniProt: P31947
#2: Protein/peptide NF-kappa-B inhibitor alpha / I-kappa-B-alpha / IkappaBalpha / Major histocompatibility complex enhancer-binding protein MAD3


Mass: 1676.719 Da / Num. of mol.: 1 / Source method: obtained synthetically / Source: (synth.) Homo sapiens (human) / References: UniProt: P25963

-
Non-polymers , 5 types, 345 molecules

#3: Chemical ChemComp-CA / CALCIUM ION


Mass: 40.078 Da / Num. of mol.: 2 / Source method: obtained synthetically / Formula: Ca
#4: Chemical ChemComp-CL / CHLORIDE ION / Chloride


Mass: 35.453 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Cl
#5: Chemical ChemComp-MG / MAGNESIUM ION


Mass: 24.305 Da / Num. of mol.: 1 / Source method: obtained synthetically / Formula: Mg
#6: Chemical
ChemComp-GOL / GLYCEROL / GLYCERIN / PROPANE-1,2,3-TRIOL / Glycerol


Mass: 92.094 Da / Num. of mol.: 7 / Source method: obtained synthetically / Formula: C3H8O3
#7: Water ChemComp-HOH / water / Water


Mass: 18.015 Da / Num. of mol.: 334 / Source method: isolated from a natural source / Formula: H2O

-
Details

Has ligand of interestN

-
Experimental details

-
Experiment

ExperimentMethod: X-RAY DIFFRACTION / Number of used crystals: 1

-
Sample preparation

CrystalDensity Matthews: 2.4 Å3/Da / Density % sol: 48.85 %
Crystal growTemperature: 277 K / Method: vapor diffusion, hanging drop
Details: 0.095 M Na-HEPES pH 7.1, 27% PEG400, 0.19 M Calcium chloride, 5% Glycerol

-
Data collection

DiffractionMean temperature: 100 K / Serial crystal experiment: N
Diffraction sourceSource: SYNCHROTRON / Site: PETRA III, DESY / Beamline: P11 / Wavelength: 1.0332 Å
DetectorType: DECTRIS PILATUS 6M-F / Detector: PIXEL / Date: Jul 2, 2017
RadiationProtocol: SINGLE WAVELENGTH / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelengthWavelength: 1.0332 Å / Relative weight: 1
ReflectionResolution: 1.127→45.492 Å / Num. obs: 108705 / % possible obs: 100 % / Redundancy: 8.8 % / Biso Wilson estimate: 9.58 Å2 / CC1/2: 0.998 / Rmerge(I) obs: 0.065 / Rpim(I) all: 0.023 / Rrim(I) all: 0.07 / Net I/σ(I): 15.1
Reflection shell

Diffraction-ID: 1

Resolution (Å)Redundancy (%)Rmerge(I) obsNum. measured allNum. unique obsCC1/2Rpim(I) allRrim(I) allNet I/σ(I) obs% possible all
1.13-1.158.60.6994586853380.8720.250.7432.7100
6.17-45.499.80.04173917560.9920.0140.04449.399.8

-
Processing

Software
NameVersionClassification
Aimless0.5.32data scaling
PHENIX1.11.1_2575refinement
PDB_EXTRACT3.25data extraction
MOSFLMdata reduction
MOLREPphasing
RefinementMethod to determine structure: MOLECULAR REPLACEMENT
Starting model: 4fr3
Resolution: 1.127→45.492 Å / SU ML: 0.11 / Cross valid method: FREE R-VALUE / σ(F): 1.33 / Phase error: 18.36
RfactorNum. reflection% reflection
Rfree0.1833 5461 5.03 %
Rwork0.1695 --
obs0.1702 108654 99.98 %
Solvent computationShrinkage radii: 0.9 Å / VDW probe radii: 1.11 Å
Displacement parametersBiso max: 79.59 Å2 / Biso mean: 14.9916 Å2 / Biso min: 2.28 Å2
Refinement stepCycle: final / Resolution: 1.127→45.492 Å
ProteinNucleic acidLigandSolventTotal
Num. atoms1901 0 102 334 2337
Biso mean--58.38 25.64 -
Num. residues----243
Refine LS restraints
Refine-IDTypeDev idealNumber
X-RAY DIFFRACTIONf_bond_d0.0072181
X-RAY DIFFRACTIONf_angle_d0.9712952
X-RAY DIFFRACTIONf_chiral_restr0.185311
X-RAY DIFFRACTIONf_plane_restr0.006392
X-RAY DIFFRACTIONf_dihedral_angle_d21.554846
LS refinement shell

Refine-ID: X-RAY DIFFRACTION / Rfactor Rfree error: 0 / % reflection obs: 100 %

Resolution (Å)Rfactor RfreeNum. reflection RfreeRfactor RworkNum. reflection Rwork
1.127-1.13980.29891980.27653417
1.1398-1.15320.26631820.26963421
1.1532-1.16730.29711510.27063391
1.1673-1.18210.23341890.24733414
1.1821-1.19760.25411910.24643419
1.1976-1.2140.25361980.23323379
1.214-1.23140.23351760.2423402
1.2314-1.24970.25241780.21963408
1.2497-1.26930.22661750.22663416
1.2693-1.29010.20891870.20253434
1.2901-1.31230.20911900.19123394
1.3123-1.33620.2091770.18983449
1.3362-1.36190.20941720.18183408
1.3619-1.38970.20951920.18673379
1.3897-1.41990.19611880.17083425
1.4199-1.4530.17931890.16683408
1.453-1.48930.15371790.15413429
1.4893-1.52960.17391940.153409
1.5296-1.57460.16071500.15463462
1.5746-1.62540.17971840.15283437
1.6254-1.68350.15871660.15573442
1.6835-1.75090.16481890.15153434
1.7509-1.83060.171890.15493462
1.8306-1.92710.16571900.1583434
1.9271-2.04780.17541860.15183456
2.0478-2.2060.1621880.14633464
2.206-2.42790.1521580.14743508
2.4279-2.77920.16391790.15963499
2.7792-3.50130.17511860.15953525
3.5013-45.4920.18511900.16763668

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242):Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more